{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:45Z","timestamp":1786119645058,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7,1]]},"DOI":"10.1097\/qai.0b013e3182167516","type":"journal-article","created":{"date-parts":[[2011,3,4]],"date-time":"2011-03-04T22:55:12Z","timestamp":1299279312000},"page":"190-196","source":"Crossref","is-referenced-by-count":29,"title":["Serologic Responses to Pneumocystis Proteins in HIV Patients With and Without Pneumocystis jirovecii Pneumonia"],"prefix":"10.1097","volume":"57","author":[{"given":"Matthew R","family":"Gingo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorrie","family":"Lucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran R","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kpandja","family":"Djawe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J","family":"Palella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison G","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H","family":"Bream","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory D","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence A","family":"Kingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D","family":"Walzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210131","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R2-3-20210131","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia.","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"R3-3-20210131","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome.","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R4-3-20210131","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1056\/NEJMc070728","article-title":"Pneumocystis pneumonia associated with infliximab in Japan.","volume":"357","author":"Harigai","year":"2007","journal-title":"N Engl J Med"},{"key":"R5-3-20210131","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2169\/internalmedicine.45.1623","article-title":"Pulmonary infectious complications associated with anti-TNF-alpha therapy (infliximab) for rheumatoid arthritis.","volume":"45","author":"Imaizumi","year":"2006","journal-title":"Intern Med"},{"key":"R6-3-20210131","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/00365540601071867","article-title":"Pneumocystis carinii pneumonia in a rheumatoid arthritis patient treated with adalimumab.","volume":"39","author":"Kalyoncu","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"R7-3-20210131","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11845-007-0087-x","article-title":"Pneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis.","volume":"176","author":"Lahiff","year":"2007","journal-title":"Ir J Med Sci"},{"key":"R8-3-20210131","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/s10165-005-0454-2","article-title":"Pneumocystis jiroveci pneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumor necrosis factor alpha neutralizing antibody.","volume":"16","author":"Mori","year":"2006","journal-title":"Mod Rheumatol"},{"key":"R9-3-20210131","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1378\/chest.118.3.712","article-title":"Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection.","volume":"118","author":"Mansharamani","year":"2000","journal-title":"Chest"},{"key":"R10-3-20210131","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199001183220304","article-title":"The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study group.","volume":"322","author":"Phair","year":"1990","journal-title":"N Engl J Med"},{"key":"R11-3-20210131","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1128\/IAI.61.5.1641-1649.1993","article-title":"Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice.","volume":"61","author":"Roths","year":"1993","journal-title":"Infect Immun"},{"key":"R12-3-20210131","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1086\/341565","article-title":"Serologic responses to epitopes of the major surface glycoprotein of Pneumocystis jiroveci differ in human immunodeficiency virus-infected and uninfected persons.","volume":"186","author":"Daly","year":"2002","journal-title":"J Infect Dis"},{"key":"R13-3-20210131","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1086\/375354","article-title":"Quantitation of anti-Pneumocystis jiroveci antibodies in healthy persons and immunocompromised patients.","volume":"187","author":"Bishop","year":"2003","journal-title":"J Infect Dis"},{"key":"R14-3-20210131","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3201\/eid1005.030497","article-title":"Enzyme-linked immunosorbent assay and serologic responses to Pneumocystis jiroveci.","volume":"10","author":"Daly","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"R15-3-20210131","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1128\/IAI.62.8.3092-3101.1994","article-title":"Molecular characterization of clustered variants of genes encoding major surface antigens of human Pneumocystis carinii.","volume":"62","author":"Garbe","year":"1994","journal-title":"Infect Immun"},{"key":"R16-3-20210131","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1128\/IAI.70.3.1069-1074.2002","article-title":"Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia.","volume":"70","author":"Gigliotti","year":"2002","journal-title":"Infect Immun"},{"key":"R17-3-20210131","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1086\/595297","article-title":"Pneumocystis colonization in immunocompetent and simian immunodeficiency virus-infected cynomolgus macaques.","volume":"199","author":"Kling","year":"2009","journal-title":"J Infect Dis"},{"key":"R18-3-20210131","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/IAI.71.1.571-574.2003","article-title":"A single-copy gene encodes KEX1, a serine endoprotease of Pneumocystis jiroveci.","volume":"71","author":"Kutty","year":"2003","journal-title":"Infect Immun"},{"key":"R19-3-20210131","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1128\/IAI.66.9.4268-4273.1998","article-title":"Characterization of major surface glycoprotein genes of human Pneumocystis carinii and high-level expression of a conserved region.","volume":"66","author":"Mei","year":"1998","journal-title":"Infect Immun"},{"key":"R20-3-20210131","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1128\/IAI.74.4.2446-2448.2006","article-title":"Active immunization against Pneumocystis carinii with a recombinant P. carinii antigen.","volume":"74","author":"Wells","year":"2006","journal-title":"Infect Immun"},{"key":"R21-3-20210131","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1172\/JCI26306","article-title":"CD4+ T cell-independent DNA vaccination against opportunistic infections.","volume":"115","author":"Zheng","year":"2005","journal-title":"J Clin Invest"},{"key":"R22-3-20210131","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1172\/JCI13826","article-title":"CD4+ T cell-independent vaccination against Pneumocystis carinii in mice.","volume":"108","author":"Zheng","year":"2001","journal-title":"J Clin Invest"},{"key":"R23-3-20210131","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1550-7408.2006.00225.x","article-title":"Antigenic variation in Pneumocystis.","volume":"54","author":"Stringer","year":"2007","journal-title":"J Eukaryot Microbiol"},{"key":"R24-3-20210131","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3201\/eid1708.060230","article-title":"Antibody response to Pneumocystis jirovecii major surface glycoprotein.","volume":"12","author":"Daly","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"R25-3-20210131","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/CVI.00140-06","article-title":"Human immunodeficiency virus-infected patients with prior Pneumocystis pneumonia exhibit increased serologic reactivity to several major surface glycoprotein clones.","volume":"13","author":"Daly","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"R26-3-20210131","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1086\/597803","article-title":"Long-term serologic responses to the Pneumocystis jirovecii major surface glycoprotein in HIV-positive individuals with and without P. jirovecii infection.","volume":"199","author":"Walzer","year":"2009","journal-title":"J Infect Dis"},{"key":"R27-3-20210131","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-1119(99)00533-8","article-title":"Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii.","volume":"242","author":"Lee","year":"2000","journal-title":"Gene"},{"key":"R28-3-20210131","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1525-1381.1999.99118.x","article-title":"Characterization of a multicopy family of genes encoding a surface-expressed serine endoprotease in rat Pneumocystis carinii.","volume":"111","author":"Russian","year":"1999","journal-title":"Proc Assoc Am Physicians"},{"key":"R29-3-20210131","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1128\/IAI.00507-10","article-title":"Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection.","volume":"78","author":"Kling","year":"2010","journal-title":"Infect Immun"},{"key":"R30-3-20210131","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/aje\/126.2.310","article-title":"The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.","volume":"126","author":"Kaslow","year":"1987","journal-title":"Am J Epidemiol"},{"key":"R31-3-20210131","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1086\/591701","article-title":"Relationship of Pneumocystis antibody response to severity of chronic obstructive pulmonary disease.","volume":"47","author":"Morris","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R32-3-20210131","first-page":"A5539","article-title":"Health care worker occupation is associated with Pneumocystis KEX1 antibody responses.","volume":"179","author":"Kristoff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R33-3-20210131","doi-asserted-by":"crossref","first-page":"e14259","DOI":"10.1371\/journal.pone.0014259","article-title":"Serum antibody levels to the Pneumocystis jirovecii major surface glycoprotein in the diagnosis of P. jirovecii pneumonia in HIV+ patients.","volume":"5","author":"Djawe","year":"2010","journal-title":"PLoS One"},{"issue":"suppl 1","key":"R34-3-20210131","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.","volume":"30","author":"Kaplan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R35-3-20210131","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/515658","article-title":"Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis.","volume":"178","author":"Kaplan","year":"1998","journal-title":"J Infect Dis"},{"issue":"RR-4","key":"R36-3-20210131","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"R37-3-20210131","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(99)03320-6","article-title":"Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.","volume":"354","author":"Helweg-Larsen","year":"1999","journal-title":"Lancet"},{"key":"R38-3-20210131","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1128\/AAC.49.2.741-748.2005","article-title":"Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs.","volume":"49","author":"Iliades","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R39-3-20210131","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/315719","article-title":"Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients.","volume":"182","author":"Kazanjian","year":"2000","journal-title":"J Infect Dis"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201107010-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:47:19Z","timestamp":1786042039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201107010-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,1]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3182167516","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,1]]}}}